SLC5A2 and COVID-19: In addition, patients receiving SGLT2 inhibitors should be educated to pause therapy if they are not eating and drinking for long periods (e.g. they have gastroenteritis or prior to surgery) or they are unwell (e.g. they have flu COVID-19 or sepsis) (80, 81, 82, 83).